Caring Brands Inc. (NASDAQ: CABR) has completed the initial $4.6 million tranche of a $9 million funding round, according to a Form 8-K filing. The company, based in Fort Pierce, Florida, issued convertible preferred shares to accredited investors on September 1, 2026.
The firm expects to finalize additional closings on a rolling basis, with subscription documents totaling $4.4 million already executed. Funds are anticipated to clear by September 4, 2026, at which point Caring Brands plans to issue 4,400 shares of Series B Preferred Stock along with warrants for up to 8.8 million common shares.
Proceeds from the initial closing will support the launch of a proprietary salesforce and the expansion of domestic and international marketing campaigns, the company said. Chief Executive Officer Dr. Glynn Wilson noted the funds would enable the company to begin funding its full marketing initiatives.
Caring Brands develops and markets skin and hair treatment products, including the Hair Enzyme Booster for hair loss and Photocil for psoriasis and vitiligo. Current revenue streams are derived from direct sales in the United States and licensing agreements in India.
